drugset / Trial / NCT01778062
Indacaterol EfectIveness In COPD Patients With Tuberculosis History
RandomizedParallel-groupDouble-blindTreatment
Summary
This clinical study will assess efficacy and safety of indacaterol (150㎍ o.d.) in patients with Chronic Obstructive Pulmonary Disease (COPD) with destroyed lung by tuberculosis.
Timeline
- Start
- 2013-02
- Primary completion
- 2014-09
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Indacaterol | Other / unclassified | 150 ug | Inhaled |